John L. Lamattina, a director at Ligand Pharmaceuticals Inc. ($LGND), sold shares on the open market twice in the last year, totaling about $859,000. His most recent sale occurred on November 7, 2025. These sales rank 5,282nd among 11,678 individual insiders, compared to an average of $8.6 million per seller and 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | M | Common Stock | 2161 | $114.15 | 32,885.0000 | 20,629,000 | 7.03% | 0.01% |
| March 6, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | M | Non-Qualified Stock Option (right to buy) | 2161 | $0.00 | 0.0000 | 20,629,000 | 100.00% | 0.01% |
| March 6, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | S | Common Stock | 2161 | $200.76 | 30,724.0000 | 20,629,000 | 6.57% | 0.01% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | M | Common Stock | 2034 | $69.51 | 32,758.0000 | 20,629,000 | 6.62% | 0.01% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | M | Common Stock | 2145 | $66.13 | 32,869.0000 | 20,629,000 | 6.98% | 0.01% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | S | Common Stock | 2145 | $205.45 | 30,724.0000 | 20,629,000 | 6.53% | 0.01% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | S | Common Stock | 2034 | $205.45 | 30,724.0000 | 20,629,000 | 6.21% | 0.01% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | M | Non-Qualified Stock Option (right to buy) | 2145 | $0.00 | 0.0000 | 20,629,000 | 100.00% | 0.01% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | M | Non-Qualified Stock Option (right to buy) | 2034 | $0.00 | 0.0000 | 20,629,000 | 100.00% | 0.01% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | A | Non-Qualified Stock Option (right to buy) | 5783 | $0.00 | 5,783.0000 | 18,290,000 | 9999.99% | 0.03% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | A | Common Stock | 1209 | $0.00 | 30,724.0000 | 18,290,000 | 4.10% | 0.01% |
| Nov. 27, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | M | Common Stock | 2406 | $52.30 | 31,921.0000 | 18,574,000 | 8.15% | 0.01% |
| Nov. 27, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | M | Non-Qualified Stock Option (right to buy) | 2406 | $0.00 | 0.0000 | 18,574,000 | 100.00% | 0.01% |
| Nov. 27, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | S | Common Stock | 2406 | $123.65 | 29,515.0000 | 18,574,000 | 7.54% | 0.01% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | A | Common Stock | 1252 | $0.00 | 29,515.0000 | 17,757,000 | 4.43% | 0.01% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | LAMATTINA JOHN L | Director | A | Non-Qualified Stock Option (right to buy) | 5444 | $0.00 | 5,444.0000 | 17,757,000 | 9999.99% | 0.03% |
| June 8, 2023 | Immunome Inc. | $IMNM | LAMATTINA JOHN L | Director | A | Stock Option (Right to Buy) | 6500 | $0.00 | 6,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 15, 2023 | Immunome Inc. | $IMNM | LAMATTINA JOHN L | Director | A | Common Stock | 15125 | $4.00 | 66,953.0000 | 0 | 29.18% | 0.00% |